Market Intelligence Ecosystem
Poly Medicure Limited (NSE:POLYMED) Q3 FY23 Earnings Concall dated Feb. 06, 2023. Corporate Participants: Himanshu Baid -- Managing Director Analysts: Rohan John -- ICICI Securities --
AMI Organics Ltd (NSE: AMIORG) Q3 FY23 Earnings Concall dated Feb. 04, 2023 Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Patel -- Chief Executive
Aarti Industries Ltd (NSE: AARTIIND) Q3 FY23 Earnings Concall dated Feb. 06, 2023 Corporate Participants: Nishid Solanki -- Investor Relations Rajendra Gogri -- Chairman and Managing
Thyrocare Technologies Ltd (NSE:THYROCARE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Rahul Guha -- Managing Director and Chief Executive Officer Sachin
Zydus Lifesciences Ltd (NSE:ZYDUSLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Ganesh N. Nayak -- Executive Director Sharvil P. Patel -- Managing Director
Emami Limited (NSE:EMAMILTD) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Mohan Goenka -- Vice Chairman & Whole-Time Director Gul Raj Bhatia -- President,
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Vineet Mayer -- Investor Relations and Corporate Finance Shyam S
GMM Pfaudler Limited (NSE:GMMPFAUDLR) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Priyanka Daga -- Deputy General Manager Tarak Patel -- Managing Director Manish
Mahindra Lifespace Developers Limited (NSE:MAHLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Arvind Subramanian -- Managing Director and Chief Executive Officer
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Anoop Poojari -- Client Manager - Citigate Dewe
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY23 Earnings Concall dated Feb. 03, 2023 Corporate Participants: M. Satish Choudhury -- Company Secretary and Chief Investor
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked about the
Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended
Max Healthcare Institute Ltd.’s gross revenue in Q3FY23 rose 13% to ₹ 1,559 crores. Consolidated Profit After Tax came at ₹ 269
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY23 Earnings Concall dated Feb. 01, 2023. Corporate Participants: R.K. Baheti -- Director, Finance and Chief Financial Officer Shaunak
Hester Biosciences Limited (NSE:HESTERBIO) Q3 FY23 Earnings Concall dated Jan. 31, 2023. Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing Director Priya
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY23 Earnings Concall dated Jan. 31, 2023 Corporate Participants: Abhishek Sharma -- Head of Investor Relations and
Procter & Gamble Hygiene & Health Care’s revenue in Q2FY23 rose 4% to ₹ 1,13,739 lakhs. Consolidated Profit After Tax came at
Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Management Update: [00:03:57] LAURUSLABS said its strong results were driven by
Laurus Labs Limited (NSE:LAURUSLABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer V V
VIMTA LABS LTD (NSE:VIMTALABS) Q3 FY23 Earnings Concall dated Jan. 30, 2023. Corporate Participants: Harita Vasireddi -- Managing Director D.R. Narahai Naidu -- Chief Financial Officer